{"log_id": 8181091138278749487, "direction": 0, "words_result_num": 49, "words_result": [{"probability": {"variance": 0.006823, "average": 0.978885, "min": 0.489636}, "location": {"width": 818, "top": 162, "height": 106, "left": 155}, "words": "后续剂量调整:随着糖尿病症状的改善,胰岛素敏感性的增加,格列美脉的需要量也应"}, {"probability": {"variance": 0, "average": 0.999542, "min": 0.998776}, "location": {"width": 68, "top": 206, "height": 31, "left": 113}, "words": "知医生"}, {"probability": {"variance": 0.000127, "average": 0.995541, "min": 0.945868}, "location": {"width": 587, "top": 220, "height": 85, "left": 118}, "words": "逐渐减少,为避免低血糖的发生,应及时减少用量,甚至停用"}, {"probability": {"variance": 4.8e-05, "average": 0.99716, "min": 0.967559}, "location": {"width": 818, "top": 229, "height": 104, "left": 162}, "words": "当病人的体重或病人的生活方式发生改变或出现其他情况,导致病人易出现低血糖或高"}, {"probability": {"variance": 0.001506, "average": 0.99174, "min": 0.756859}, "location": {"width": 817, "top": 297, "height": 104, "left": 168}, "words": "从其他口服降糖药改为本品:本品与其他口服降糖药没有确切的剂量关系。当用本品代"}, {"probability": {"variance": 0.000434, "average": 0.990136, "min": 0.930267}, "location": {"width": 396, "top": 304, "height": 67, "left": 123}, "words": "血糖(见注意事项)时也应考虑调整剂量"}, {"probability": {"variance": 5.1e-05, "average": 0.996214, "min": 0.962042}, "location": {"width": 859, "top": 333, "height": 103, "left": 128}, "words": "替其他口服降糖药时,建议起始剂量为每天1mg(半片),即使正在使用最大剂量的其他口"}, {"probability": {"variance": 0.003371, "average": 0.985312, "min": 0.6407}, "location": {"width": 850, "top": 366, "height": 102, "left": 132}, "words": "服降糖药时也应如此。所有本品剂量的增加,都应该遵照上述“初始剂量及剂墅调整方法"}, {"probability": {"variance": 0.006694, "average": 0.979547, "min": 0.531268}, "location": {"width": 859, "top": 398, "height": 101, "left": 134}, "words": "的要求去做。考虑到以前降糖药的效力及持续时间,需要中断一下治疗,以避免药物累加作"}, {"probability": {"variance": 3.8e-05, "average": 0.997054, "min": 0.97143}, "location": {"width": 853, "top": 462, "height": 101, "left": 144}, "words": "【不良反应】据国外资料报道:两个大范围的对照研究,研究时间为一年,结果表明低血"}, {"probability": {"variance": 1e-06, "average": 0.999354, "min": 0.99739}, "location": {"width": 156, "top": 489, "height": 42, "left": 138}, "words": "用而引起低血糖"}, {"probability": {"variance": 3.9e-05, "average": 0.996624, "min": 0.972618}, "location": {"width": 816, "top": 527, "height": 99, "left": 188}, "words": "为了评价格列美脲的安全性,在美国及其他国家进行了对照试验(其中在美国进行的对"}, {"probability": {"variance": 0.006463, "average": 0.957144, "min": 0.692389}, "location": {"width": 431, "top": 530, "height": 67, "left": 142}, "words": "糖的发生率在0.9-1.7%。血糖值小于60mg/dl"}, {"probability": {"variance": 0.000314, "average": 0.992695, "min": 0.899839}, "location": {"width": 860, "top": 561, "height": 101, "left": 147}, "words": "照试验受试者为2013名,在其他国家的受试者总数为1551名),在受试者中,有1650名以"}, {"probability": {"variance": 0.000204, "average": 0.995315, "min": 0.931228}, "location": {"width": 847, "top": 593, "height": 101, "left": 152}, "words": "上患者接受了一年的治疗,除观察到低血糖反应外,在美国进行的以安慰剂为对照的试验中"}, {"probability": {"variance": 0.000263, "average": 0.996085, "min": 0.896654}, "location": {"width": 839, "top": 626, "height": 99, "left": 153}, "words": "还有以下的不良反应,其发生率≥1%,这些不良反应有可能或很有可能与格列美脲有关"}, {"probability": {"variance": 0, "average": 0.99941, "min": 0.998321}, "location": {"width": 133, "top": 721, "height": 33, "left": 157}, "words": "不良反应如下"}, {"probability": {"variance": 0.003695, "average": 0.983696, "min": 0.740715}, "location": {"width": 358, "top": 746, "height": 57, "left": 407}, "words": "格列美脲不良反应发生率≥1%的情况"}, {"probability": {"variance": 0, "average": 0.999283, "min": 0.998631}, "location": {"width": 75, "top": 806, "height": 33, "left": 753}, "words": "安慰剂"}, {"probability": {"variance": 0.001689, "average": 0.976006, "min": 0.904827}, "location": {"width": 97, "top": 831, "height": 36, "left": 434}, "words": "格列美脲"}, {"probability": {"variance": 0, "average": 0.999276, "min": 0.999276}, "location": {"width": 20, "top": 841, "height": 21, "left": 873}, "words": "%"}, {"probability": {"variance": 0.000136, "average": 0.988133, "min": 0.976452}, "location": {"width": 21, "top": 854, "height": 22, "left": 697}, "words": "29"}, {"probability": {"variance": 2e-06, "average": 0.998725, "min": 0.996161}, "location": {"width": 94, "top": 886, "height": 35, "left": 203}, "words": "总治疗组"}, {"probability": {"variance": 0, "average": 0.998186, "min": 0.997716}, "location": {"width": 34, "top": 877, "height": 21, "left": 397}, "words": "746"}, {"probability": {"variance": 4e-05, "average": 0.993119, "min": 0.986531}, "location": {"width": 55, "top": 864, "height": 22, "left": 535}, "words": "100%"}, {"probability": {"variance": 0.000545, "average": 0.984579, "min": 0.944309}, "location": {"width": 52, "top": 897, "height": 26, "left": 538}, "words": "1.7%"}, {"probability": {"variance": 1e-06, "average": 0.998761, "min": 0.997766}, "location": {"width": 50, "top": 922, "height": 28, "left": 227}, "words": "头晕"}, {"probability": {"variance": 6.3e-05, "average": 0.992311, "min": 0.981431}, "location": {"width": 46, "top": 930, "height": 27, "left": 542}, "words": "15%"}, {"probability": {"variance": 0, "average": 0.999811, "min": 0.999711}, "location": {"width": 50, "top": 956, "height": 27, "left": 229}, "words": "乏力"}, {"probability": {"variance": 0.000526, "average": 0.981604, "min": 0.942933}, "location": {"width": 43, "top": 966, "height": 26, "left": 545}, "words": "1.5%"}, {"probability": {"variance": 0, "average": 0.999911, "min": 0.999865}, "location": {"width": 46, "top": 992, "height": 27, "left": 234}, "words": "头痛"}, {"probability": {"variance": 0.022219, "average": 0.89332, "min": 0.682519}, "location": {"width": 49, "top": 1000, "height": 26, "left": 549}, "words": "11%"}, {"probability": {"variance": 4e-06, "average": 0.997808, "min": 0.995711}, "location": {"width": 47, "top": 1028, "height": 24, "left": 237}, "words": "恶心"}, {"probability": {"variance": 0.00635, "average": 0.979655, "min": 0.576224}, "location": {"width": 814, "top": 1059, "height": 96, "left": 232}, "words": "胃肠道反应:呕吐、腹痛、腹泻均有报导,但安慰剂对照试验的发生率小于1%。有报"}, {"probability": {"variance": 0.000399, "average": 0.993739, "min": 0.883019}, "location": {"width": 814, "top": 1124, "height": 96, "left": 238}, "words": "皮肤反应:过敏性皮肤反应的发生率小于1%,表现为瘙痒、红斑、荨麻疹样、麻疹样"}, {"probability": {"variance": 0.003318, "average": 0.981267, "min": 0.758334}, "location": {"width": 397, "top": 1129, "height": 62, "left": 192}, "words": "道转氨酶升高。但很少有胆汁性黄疸发生"}, {"probability": {"variance": 0.002841, "average": 0.98545, "min": 0.682372}, "location": {"width": 849, "top": 1155, "height": 102, "left": 198}, "words": "或斑丘疹样皮损等。上述皮肤反应可能仅短暂出现,即使继续使用格列美脲也可能自行消失"}, {"probability": {"variance": 0.003825, "average": 0.980427, "min": 0.61953}, "location": {"width": 858, "top": 1187, "height": 103, "left": 201}, "words": "如果皮肤反应持续存在,应该停药。有报道使用磺酰脲类药物的患者发生迟发性的血卟啉症"}, {"probability": {"variance": 0.000775, "average": 0.992297, "min": 0.830988}, "location": {"width": 816, "top": 1252, "height": 96, "left": 246}, "words": "血液反应:有报导使用磺酰脲类药物会引起白细胞减少、粒细胞缺乏、血小板减少、溶"}, {"probability": {"variance": 0, "average": 0.999483, "min": 0.999074}, "location": {"width": 135, "top": 1281, "height": 37, "left": 205}, "words": "和光敏性反应"}, {"probability": {"variance": 2e-06, "average": 0.999103, "min": 0.99454}, "location": {"width": 458, "top": 1316, "height": 70, "left": 209}, "words": "血性贫血、再生障碍性贫血和各类血细胞减少症"}, {"probability": {"variance": 0.005404, "average": 0.97942, "min": 0.620205}, "location": {"width": 812, "top": 1318, "height": 96, "left": 255}, "words": "代谢反应:有报导使用磺酰脲类药物的患者发生肝性卟啉症,但是还没有使用格列美脲"}, {"probability": {"variance": 0.001147, "average": 0.987981, "min": 0.806007}, "location": {"width": 848, "top": 1352, "height": 100, "left": 215}, "words": "引起这类反应的报导。有关格列美脉和所有其他磺酰脲类药物所引起的低钠血症均有报道,"}, {"probability": {"variance": 6e-06, "average": 0.998355, "min": 0.985939}, "location": {"width": 858, "top": 1382, "height": 106, "left": 217}, "words": "最常见的发生在合并使用其他药物治疗的患者,或处于引起低钠血症的状态,或抗利尿素"}, {"probability": {"variance": 0.000199, "average": 0.995048, "min": 0.917148}, "location": {"width": 816, "top": 1451, "height": 102, "left": 264}, "words": "其他反应:使用格列美脲的患者会发生视力调节变化、视力模糊,被认为与血糖变化有"}, {"probability": {"variance": 5.7e-05, "average": 0.996134, "min": 0.972027}, "location": {"width": 261, "top": 1468, "height": 52, "left": 230}, "words": "(ADH)的释放增加的情况"}, {"probability": {"variance": 4.4e-05, "average": 0.997582, "min": 0.960131}, "location": {"width": 846, "top": 1488, "height": 100, "left": 225}, "words": "关,且在治疗初始较明显,这种情形也可见于未经治疗的糖尿病患者,可通过治疗而减少"}, {"probability": {"variance": 0.000847, "average": 0.986945, "min": 0.888064}, "location": {"width": 849, "top": 1523, "height": 98, "left": 229}, "words": "在格列美脲的安慰剂对照试验中,视力模糊发生率在安慰剂组为0.7%,格列美脲组为0.4%"}, {"probability": {"variance": 0.001064, "average": 0.979662, "min": 0.923171}, "location": {"width": 75, "top": 1619, "height": 32, "left": 241}, "words": "【禁忌】"}], "language": 3}